Acute pancreatitis in patients with type 2 diabetes mellitus treated with dipeptidyl peptidase-4 inhibitors: a population-based nested case-control study.


BACKGROUND Concern about an increasing risk of acute pancreatitis associated with incretin-based drugs, including dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagon-like peptide-1 analogs, has emerged recently. OBJECTIVE This nested case-control study examined the association between the use of DPP-4 inhibitors and acute pancreatitis using Taiwan's… (More)
DOI: 10.1007/s40264-014-0171-x


2 Figures and Tables

Slides referencing similar topics